Drug Type Small molecule drug |
Synonyms KK-6168 |
Action- |
Mechanism Hepatitis C virus NS 5 protein inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis C | Preclinical | South Korea | - | |
| Hepatitis C | Preclinical | South Korea | - |





